Xermelo

Chemical Nametelotristat ethyl
Dosage FormTablet (oral; 250 mg)
Drug ClassInhibitors
SystemDigestive
CompanyLexicon Pharmaceuticals, Inc.
Approval Year2017

Indication

  • To treat carcinoid syndrome diarrhea in conjunction with somatostatin analog therapy in adults.
Last updated on 10/13/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xermelo (Telotristat Ethyl) Prescribing Information 2017Lexicon Pharmaceuticals, Inc., The Woodlands, TX